(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 4.89% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Bausch & Lomb's revenue in 2025 is $4,891,000,000.On average, 6 Wall Street analysts forecast BLCO's revenue for 2025 to be $1,802,116,384,772, with the lowest BLCO revenue forecast at $1,795,868,884,250, and the highest BLCO revenue forecast at $1,805,801,896,975. On average, 6 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,902,427,427,995, with the lowest BLCO revenue forecast at $1,889,643,318,600, and the highest BLCO revenue forecast at $1,916,547,734,614.
In 2027, BLCO is forecast to generate $1,996,086,502,098 in revenue, with the lowest revenue forecast at $1,961,513,460,549 and the highest revenue forecast at $2,021,440,632,086.